老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ra Pharmaceuticals Inc.

48.00
0.0000
成交量：- -
成交額：- -
市值：22.72億
市盈率：-20.73
高：48.00
開：48.00
低：48.00
收：48.00
52周最高：48.02
52周最低：19.64
股本：4,732.89萬
流通股本：3,590.33萬
量比：- -
換手率：- -
股息：- -
股息率：- -
每股收益(TTM):-2.3147
每股收益(LYR):-2.3147
淨資產收益率：-43.77%
總資產收益率：-26.57%
市淨率：8.67
市盈率(LYR):-20.73

資料載入中...

總覽公司新聞資訊公告
2020/04/06

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/04/03

[修訂]年度報告

[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]
2020/04/02

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/04/02

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/04/02

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/04/02

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/04/02

重要事件披露

Current report, items 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 8.01, and 9.01
2020/04/02

交易所摘牌聲明

Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2020/03/31

重要事件披露

Current report, item 8.01
2020/03/16

重要事件披露

8-K - Current report
2020/02/28

重要事件披露

8-K - Current report
2020/02/27

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/10

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/12/18

重要事件披露

Current report, items 5.07 and 8.01
2019/11/25

重要事件披露

Current report, item 8.01
2019/11/08

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/11/07

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/10/17

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/10/11

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/10/10

重要事件披露

Current report, items 1.01, 7.01, and 9.01
更多